India proposes price regulation for patented drugs

02/27/2013 | Economic Times (India), The

A government panel in India has recommended that prices for expensive drugs to treat critical diseases like HIV, cancer and hepatitis be based on the nation's per capita income, which could substantially reduce their costs and make them more affordable for patients. Some in the industry warn, however, that the regulations could backfire and instead prevent companies from offering new drugs in India.

View Full Article in:

Economic Times (India), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Manager/Senior Manager, Health Services Analytics
Avalere Health
Washington, DC
Manager/Senior Manager, Health Economist
Avalere Health
Washington, DC
Director, Health Services Analytics
Avalere Health
Washington, DC
Director/Vice President. Health Actuary
Avalere Health
Washington, DC
Director of Governmental Programs
Bluegrass Family Health
Lexington, KY